c-Kit Inhibitors
Santa Cruz Biotechnology now offers a broad range of c-Kit Inhibitors. C-Kit regulates a variety of biological responses including chemotaxis, cell proliferation, apoptosis, and adhesion. Mutations in Kit are integral for tumor growth and progression in various cancers. C-Kit Inhibitors offered by Santa Cruz inhibit c-Kit and, in some cases, other proto-oncogenes and receptor tyrosine kinase related proteins. View detailed c-Kit Inhibitor specifications, including c-Kit Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
Items 1 to 10 of 38 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib mesylate | 220127-57-1 | sc-202180 sc-202180A | 25 mg 100 mg | $44.00 $109.00 | 61 | |
Imatinib mesylate (CAS 220127-57-1) is a compound known for its role as an inhibitor of c-Kit, a protein associated with cellular processes. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib inhibits c-kit by competitively binding to the ATP-binding site of the tyrosine kinase domain, preventing autophosphorylation and downstream signaling. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib (CAS 284461-73-0) is a compound acting as an inhibitor of c-Kit. It has an impact on cellular processes by targeting specific molecular pathways. | ||||||
Sunitinib Malate | 341031-54-7 | sc-220177 sc-220177A sc-220177B | 10 mg 100 mg 3 g | $193.00 $510.00 $1072.00 | 4 | |
Sunitinib Malate (CAS 341031-54-7) is a compound acting as a c-Kit inhibitor. It hinders c-Kit's activity without clinical connotations. | ||||||
VEGFR2 Kinase Inhibitor III | 204005-46-9 | sc-202851 | 5 mg | $162.00 | 7 | |
VEGFR2 Kinase Inhibitor III (CAS 204005-46-9) is a compound known for its inhibitory action on c-Kit, a protein involved in cellular processes. It modulates specific pathways without clinical connotations. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib inhibits c-kit by binding to its ATP-binding site, thus blocking the kinase activity and downstream signaling pathways. | ||||||
PDGFR Tyrosine Kinase Inhibitor III | 205254-94-0 | sc-204173 | 1 mg | $169.00 | 6 | |
PDGFR Tyrosine Kinase Inhibitor III (CAS 205254-94-0) targets c-Kit, influencing cellular processes. It modulates specific molecular interactions without clinical connotations. | ||||||
AAL-993 | 269390-77-4 | sc-221195 sc-221195A | 5 mg 25 mg | $255.00 $816.00 | ||
AAL-993 (CAS 269390-77-4) is a compound acting as a c-Kit inhibitor, targeting a specific protein function. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
Nilotinib inhibits c-kit by binding to the ATP-binding pocket of the kinase domain, preventing tyrosine phosphorylation and signaling. | ||||||
PKC-412 | 120685-11-2 | sc-200691 sc-200691A | 1 mg 5 mg | $51.00 $112.00 | 10 | |
Midostaurin inhibits c-kit by targeting its kinase domain, disrupting signaling cascades and inhibiting cell proliferation. | ||||||